Invesco’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$59.7M Sell
571,549
-285,452
-33% -$29.8M 0.01% 989
2025
Q1
$100M Buy
857,001
+164,537
+24% +$19.2M 0.02% 801
2024
Q4
$58.6M Buy
692,464
+67,285
+11% +$5.69M 0.01% 980
2024
Q3
$56.2M Buy
625,179
+67,318
+12% +$6.05M 0.01% 994
2024
Q2
$44.9M Buy
557,861
+312,208
+127% +$25.1M 0.01% 1057
2024
Q1
$19.6M Buy
245,653
+199,490
+432% +$15.9M ﹤0.01% 1466
2023
Q4
$3.67M Sell
46,163
-16,278
-26% -$1.3M ﹤0.01% 2391
2023
Q3
$4.36M Sell
62,441
-109,131
-64% -$7.63M ﹤0.01% 2276
2023
Q2
$12.3M Buy
171,572
+111,045
+183% +$7.98M ﹤0.01% 1660
2023
Q1
$3.73M Sell
60,527
-78,932
-57% -$4.87M ﹤0.01% 2354
2022
Q4
$10.8M Sell
139,459
-31,591
-18% -$2.44M ﹤0.01% 1793
2022
Q3
$7.63M Buy
171,050
+158,821
+1,299% +$7.09M ﹤0.01% 1962
2022
Q2
$469K Sell
12,229
-240
-2% -$9.2K ﹤0.01% 3334
2022
Q1
$516K Buy
12,469
+56
+0.5% +$2.32K ﹤0.01% 3339
2021
Q4
$469K Sell
12,413
-1,192
-9% -$45K ﹤0.01% 3374
2021
Q3
$448K Sell
13,605
-150,778
-92% -$4.96M ﹤0.01% 3450
2021
Q2
$11.1M Buy
164,383
+32,250
+24% +$2.18M ﹤0.01% 1985
2021
Q1
$7.48M Sell
132,133
-266,959
-67% -$15.1M ﹤0.01% 2138
2020
Q4
$32.5M Sell
399,092
-28,396
-7% -$2.31M 0.01% 1194
2020
Q3
$30.5M Sell
427,488
-71,151
-14% -$5.07M 0.01% 1119
2020
Q2
$41M Sell
498,639
-159,583
-24% -$13.1M 0.01% 1001
2020
Q1
$38.7M Buy
658,222
+46,863
+8% +$2.76M 0.02% 921
2019
Q4
$63.2M Sell
611,359
-337,946
-36% -$34.9M 0.02% 896
2019
Q3
$19.2M Buy
949,305
+141,796
+18% +$2.87M 0.01% 1434
2019
Q2
$20.8M Sell
807,509
-242,969
-23% -$6.26M 0.01% 1412
2019
Q1
$14.9M Buy
+1,050,478
New +$14.9M 0.01% 1385